Adams et al., 2016 |
Puerto Rico |
11.15–07.16 |
Epidemiological report |
Pregnant women in Puerto Rico |
672 |
Update on the prevalence of Zika virus infection among pregnant women. |
Adhikari et al., 2017 |
USA |
03.16–10.16 |
Prospective, observational |
Pregnant Hispanic women receiving prenatal care for travel to area with active Zika transmission |
29 |
Report the baseline prevalence of travel-associated Zika infection in pregnant women, determine travel characteristics of women with evidence of Zika infection and evaluate the maternal and neonatal outcomes. |
Aragao et al., 2017 |
Brazil |
12.15–11.16 |
Retrospective study |
Infants with congenital Zika syndrome 1 year of age or younger |
19 |
Review neuroimaging of infants to detect cases without microcephaly and compare them with those with microcephaly. |
Besnard et al., 2016 |
French Polynesia |
10.13–03.14 |
Retrospective, case series |
Infants of pregnancies beginning between June 2013 and August 2014 |
19 |
Detecting congenital cerebral malformations and dysfunction in fetuses and newborns. |
Bhatnagar et al., 2017 |
USA, Brazil, Colombia |
12.15–07.16 |
Case series, tissue analysis |
Pregnant women suspected with Zika virus infection |
32 |
Investigating the mechanisms of Zika virus intrauterine transmission, replication and tropism and persistence. |
Brasil et al., 2016 |
Brazil |
09.15–05.16 |
Prospective, cohort study |
Pregnant women presented to acute febrile illness or rash |
116 |
Characterizing the spectrum of ZIKV disease in pregnant women and infants. |
Gregianini et al., 2017 |
Brazil |
10.15–12.16 |
Epidemiological report |
Pregnant women with suspected ZIKV infection |
6 |
Surveillance of Zika infection and microcephaly associated with congenital infection. |
Guillmette-Artur et al., 2016 |
French Polynesia |
06.13–05.14 |
Retrospective, case series |
Fetuses with intrauterine Zika virus infection |
3 |
Analyzing the MRI cerebral findings in fetuses with intrauterine Zika virus infection. |
Hall et al., 2017 |
USA |
01.16–07.17 |
Epidemiological report |
Pregnant women with confirmed ZIKV infection |
15 |
Surveillance of the Zika virus-associated neonatal birth defects. |
Hamer et al., 2017 |
Americas |
01.13–02.16 |
Case series |
Recently travelled pregnant women with confirmed, probable or clinically suspected Zika infection |
4 |
Describing the clinical manifestations and epidemiology of Zika infection in exposed travellers. |
Honein et al., 201724
|
USA |
01.15–09.16 |
Prospective, cohort study |
Completed pregnancies with maternal, fetal or infant evidence of possible Zika infection |
442 |
Estimating the proportion of fetuses or infants with birth defects after maternal Zika virus infection by trimester of infection and maternal symptoms. |
Kam et al., 2017 |
Brazil |
02.16–08.16 |
Prospective, cohort study |
Acute ZIKV-infected adult patients |
6 |
Investigating the clinical and immunological response in acute ZIKV-infected patients. |
Meaney-Delman et al., 2016a |
USA |
08.15–02.16 |
Epidemiological report, case series |
Pregnant travellers with laboratory-confirmed Zika disease |
9 |
Update on the prevalence of Zika virus infection among pregnant women. |
Meaney-Delman et al., 2016b |
USA |
N/R |
Case series |
Pregnant women who had travelled to or lived in area with active Zika transmission |
5 |
Investigating the clinical and laboratory characteristics of pregnant women with Zika virus RNA in serum. |
Millet et al., 2017 |
Spain |
01.16–12.16 |
Cross-sectional, population-based |
Imported pregnant ZIKV cases reported to Public Health Agency of Barcelona |
6 |
Describe the diagnosed ZIKV cases and analyze the surveillance, prevention and control measures. |
Rao et al., 2017 |
USA |
01.16–08.16 |
Longitudinal, observational study |
Pregnant women who had travelled to or had sexual contact with a person who travelled to an area with active Zika transmission |
5 |
Evaluating pregnant patients with potential exposure to Zika virus infection. |
Raegan-Steiner et al., 201730
|
USA |
01.16–12.16 |
Epidemiological report |
Completed pregnancies reported to US Zika Pregnancy Registry |
449 |
Examining placental and fetal tissue specimens for Zika virus infection. |
Reynolds et al., 2017 |
USA |
01.16–12.16 |
Epidemiological report |
Completed pregnancies with laboratory-confirmed Zika virus infection reported to US Zika Pregnancy Registry |
250 |
Analysis of completed pregnancies with laboratory evidence of possible Zika virus infection reported in 2016. |
Schaub et al., 2017 |
Martinique |
01.16–11.16 |
Prospective, case series |
Pregnant women with suspected Zika infection or any fetal abnormalities at ultrasound examination |
551 |
Prospective analysis of fetal and maternal fluids and tissues in fetuses with confirmed Zika virus infection cases. |
de Oliveira-Szejnfeld et al., 2016 |
Brazil |
06.15–05.16 |
Retrospective, review |
Patients with rash occurring during pregnancy or suspected fetal CNS abnormality |
16 |
Document the imaging findings associated with congenital Zika virus infection. |
Sohan and Cyrus, 2017 |
Trinidad and Tobago |
03.16–09.16 |
Observational, case series |
Pregnant women infected with Zika in limited-resource setting |
100 |
Evaluating the fetal brain in pregnant women infected with Zika virus in a limited-resource setting. |
Zambrano et al., 2017 |
Ecuador |
06.16–07.16 |
Case-control study |
Pregnant women in third trimester of pregnancy |
32 |
Examining the presence of ZIKV in both plasma and cervical cytology of pregnant women. |
Zin et al., 2017 |
Brazil |
01.16–10.16 |
Descriptive, case series |
Mother-infant pairs with PCR-confirmed Zika virus infection in maternal specimens |
112 |
Evaluating eye findings in infants with confirmed Zika virus infection during pregnancy. |
Pacheco et al., 2016 |
Colombia |
08.15–04.16 |
Epidemiological report |
Pregnant women with clinical symptoms of Zika disease |
1484 |
Clinically assessing patients and evaluated infant microcephaly. |
Pomar et al., 2017 |
French Guiana |
01.16–07.16 |
Prospective, cohort study |
Pregnant women with biologically confirmed ZIKV infection |
301 |
Establishing the incidence of fetal central nervous system anomalies, congenital infection and fetal loss in pregnant women infected with ZIKV. |